Bliss GVS Pharma Limited announced the approved of the final dividend of ₹ 0.50 per equity share in its 40th annual general meeting (AGM) held on 31 July 2025. The AGM also included Dr. Vibha Gagan Sharma as director and appointment of AVS & Associates as Secretary Auditor.
The shareholders approve the following proposals:
The record date for dividend is July 24, 2025.
Voting details:
The results of voting for each proposal are given below:
1. Adopting Audited Standalone and Consolidated Financial Statements:
2. Final dividend announcement:
3. Re -appointment of Dr. Vibha Gagan Sharma:
4. Messrs AVS & Associates appointment as Secretarial Auditor:
All proposals were passed by significant majority, which reflects strong shareholder confidence.
The AGM Company Act, 2013 and were held in compliance with the rules of SEBI, ensuring a transparent and fair voting process.
All proposals were passed by significant majority, which reflects strong shareholder confidence.